Navigation Links
Hepatitis C Causing Liver Damage in Greater Numbers: Study
Date:5/22/2012

e baby boom generation -- be tested for hepatitis C.

Because this study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

The American Academy of Family Physicians has more about hepatitis C.

-- Robert Preidt

SOURCE: Digestive Disease Week, news release, May 22, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Test Baby Boomers for Hepatitis C, Says CDC
2. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
3. Hepatitis C drug can cause depression
4. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
5. Over 20 million individuals infected with hepatitis E in Asia and Africa
6. Broader screening for hepatitis C would be cost effective, study suggests
7. Hepatitis C Now Kills More Americans Than HIV
8. MIT: Stem cells could drive hepatitis research forward
9. Stem Cells May Further Hepatitis C Research
10. Statins May Stave Off Liver Cancer in People With Hepatitis B
11. Many U.S. Adults Not Vaccinated for Hepatitis B
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hepatitis C Causing Liver Damage in Greater Numbers: Study
(Date:8/31/2015)... ... September 01, 2015 , ... Spinal fusion surgery ... once required a long, arduous recovery. However, today’s minimally invasive fusions achieve similar ... loss and minimal muscle damage. These advantages of minimally invasive surgery redeem the ...
(Date:8/31/2015)... ... 2015 , ... Dental clinicians from Newcastle University, United Kingdom, ... learn more about its integrated approach to diabetes care. , Philip Preshaw, BDS, ... Medicine at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. The ... 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The meeting ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... Marketing and Corporate Communications. In this capacity, Michael will provide strategic leadership for ... industry leader in consumer-focused programs that have contributed to the company’s rapid growth. ...
(Date:8/31/2015)... ... 31, 2015 , ... In an article published August 24th on ... Open Journal that discusses the future of 3-D printing technology as it relates to ... implants, prosthetics, and other 3-D printed tools could be used to aid in the ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
... ... phenomenon. , ... 30, 2010 -- A study by university scientists have found that, though rare, menopause is ... similar symptoms to their female counterparts going menopause., , ,Despite being rare, some men show ...
... Eating a healthy ... to blindness. , ... 2010 -- In some cases cataracts can lead to blindness. A study has now found that ... that reducing the levels of fatty food and salt consumed significantly protected women from the lens-clouding ...
... ... LLC is currently producing the first of an original DVD series, ... effort to reclaim and restore the health, happiness and innocence of ... part of the production which is scheduled for release July 31, ...
... ... a unique business opportunity for entrepreneurs around the world. , ... (PRWEB) July 1, 2010 -- Following ... international appeal. KYSS’ first-of-its-kind home based business opportunity is designed to appeal to a ...
... ... achieve greater athletic outcomes and increase their performance. , ... Pittsburgh, PA (PRWEB) June 28, ... premiere health care facilities, is an organization of physicians and health care professionals ...
... ... resource planning solution provider, announces a $300 discount off the $995 fee for members ... the Resource Planning Summit ( www.resourceplanningsummit.com ), scheduled for September 19-21, at the La ... ...
Cached Medicine News:Health News:Male Menopause 'Rare But Real' - Age UK 2Health News:Healthy Diet 'Wards off Cataracts' - Age UK 2Health News:KidsPlay Unplugged, LLC Launches Website; Announces Production of Upcoming DVD's Encouraging Children to Engage in Free Spirited and Imaginary Play 2Health News:KidsPlay Unplugged, LLC Launches Website; Announces Production of Upcoming DVD's Encouraging Children to Engage in Free Spirited and Imaginary Play 3Health News:KYSS International creates worldwide buzz by announcing plans for global expansion 2Health News:Allegheny Medical's SportsCare Programs Combine Lifestyle, Fitness and Behavior Management with Quality Medical Treatments 2Health News:2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members 2Health News:2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members 3
(Date:8/31/2015)... Aug. 31, 2015  Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today it has completed enrollment of the ... Committee (DRC) earlier this year, into the company,s ... first-in-class innate defense regulator (IDR) and is being ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... , HELSINKI, Dec. 14 Cancer ... with the introduction of RapidArc® radiotherapy technology from Varian Medical ... radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic ... radiotherapy to treat patients with multiple brain metastases and cancers ...
... , WALTHAM, Mass., Dec. ... authority on medical technology market intelligence, increased use of safety ... be a key driver of the enteral feeding device markets ... and European Markets for Enteral Feeding Devices 2010 report ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
... designed for PCR amplification and target ... systems. The NGEN product line includes ... associated with cystic fibrosis, thrombosis, and ... for the detection of sequences associated ...
... pregnancy testing, our new ICON 25 hCG ... you fast, accurate results, plus Beckman Coulter ... hCG offers CLIA waived simplicity for urine ... For the hospital, it's the perfect complement ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: